Log In
Print this Print this

Seebri Breezhaler, glycopyrronium bromide (Seebri Neohaler) (NVA237) (formerly AD 237)

Also known as: Enurev Breezhaler, Tovanor Breezhaler

  Manage Alerts
Collapse Summary General Information
Company Sosei Group Corp.
DescriptionInhaled long-acting muscarinic receptor antagonist (LAMA)
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
PartnerNovartis AG;
Pfizer Inc.;
Vectura Group plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today